$WIZP Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Mawson Infrastructure Group Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Mawson Infrastructure Group Inc.. Get notifications about new insider transactions in Mawson Infrastructure Group Inc. for free.
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 11 2021 | WIZP | Wize Pharma, Inc. | Rubini Jonathan Brian | 10% Owner | Buy | P | 0.12 | 10,416,667 | 1,250,000 | 17,516,715 | 7.1 M to 17.5 M (+146.71 %) |
Mar 11 2021 | WIZP | Wize Pharma, Inc. | Rimon Gold Assets Ltd | 10% Owner | Buy | P | 0.12 | 10,833,333 | 1,300,000 | 17,761,199 | 6.9 M to 17.8 M (+156.37 %) |
Mar 11 2021 | WIZP | Wize Pharma, Inc. | Eisenberg Or | CFO and Secretary | Buy | P | 0.12 | 833,333 | 100,000 | 1,013,433 | 180.1 K to 1 M (+462.71 %) |
Mar 11 2021 | WIZP | Wize Pharma, Inc. | Danenberg Noam | Chief Executive Off ... | Buy | P | 0.12 | 2,916,667 | 350,000 | 3,165,705 | 249 K to 3.2 M (+1,171.17 %) |
Dec 31 2020 | WIZP | Wize Pharma, Inc. | Rimon Gold Assets Ltd | 10% Owner | Option Exercise | X | 0.27 | 350,334 | 94,590 | 0 | |
Dec 31 2020 | WIZP | Wize Pharma, Inc. | Rimon Gold Assets Ltd | 10% Owner | Option Exercise | X | 0.16 | 520,820 | 83,331 | 0 | |
Dec 31 2020 | WIZP | Wize Pharma, Inc. | Rimon Gold Assets Ltd | 10% Owner | Option Exercise | X | 0.27 | 3,385,212 | 914,007 | 0 | |
Dec 31 2020 | WIZP | Wize Pharma, Inc. | Rimon Gold Assets Ltd | 10% Owner | Option Exercise | X | 0.16 | 400,000 | 64,000 | 0 | |
Dec 31 2020 | WIZP | Wize Pharma, Inc. | Rimon Gold Assets Ltd | 10% Owner | Sell | S | 0.00 | 2,919 | 0 | 7,520,077 | 7.5 M to 7.5 M (-0.04 %) |
Dec 31 2020 | WIZP | Wize Pharma, Inc. | Rimon Gold Assets Ltd | 10% Owner | Buy | X | 0.00 | 350,334 | 0 | 7,522,996 | 7.2 M to 7.5 M (+4.88 %) |
Dec 31 2020 | WIZP | Wize Pharma, Inc. | Rimon Gold Assets Ltd | 10% Owner | Sell | S | 0.00 | 4,340 | 0 | 7,873,330 | 7.9 M to 7.9 M (-0.06 %) |
Dec 31 2020 | WIZP | Wize Pharma, Inc. | Rimon Gold Assets Ltd | 10% Owner | Buy | X | 0.00 | 520,820 | 0 | 7,877,670 | 7.4 M to 7.9 M (+7.08 %) |
Dec 31 2020 | WIZP | Wize Pharma, Inc. | Rimon Gold Assets Ltd | 10% Owner | Sell | S | 0.00 | 28,210 | 0 | 7,356,850 | 7.4 M to 7.4 M (-0.38 %) |
Dec 31 2020 | WIZP | Wize Pharma, Inc. | Rimon Gold Assets Ltd | 10% Owner | Buy | X | 0.00 | 3,385,212 | 0 | 7,385,060 | 4 M to 7.4 M (+84.63 %) |
Dec 31 2020 | WIZP | Wize Pharma, Inc. | Rimon Gold Assets Ltd | 10% Owner | Sell | S | 0.00 | 3,077 | 0 | 3,999,848 | 4 M to 4 M (-0.08 %) |
Dec 31 2020 | WIZP | Wize Pharma, Inc. | Rimon Gold Assets Ltd | 10% Owner | Buy | X | 0.00 | 400,000 | 0 | 4,002,925 | 3.6 M to 4 M (+11.10 %) |
Dec 31 2020 | WIZP | Wize Pharma, Inc. | Danenberg Noam | Chief Executive Off ... | Option Exercise | X | 0.27 | 63,236 | 17,074 | 0 | |
Dec 31 2020 | WIZP | Wize Pharma, Inc. | Danenberg Noam | Chief Executive Off ... | Option Exercise | X | 0.16 | 173,607 | 27,777 | 0 | |
Dec 31 2020 | WIZP | Wize Pharma, Inc. | Danenberg Noam | Chief Executive Off ... | Option Exercise | X | 0.27 | 1,505,162 | 406,394 | 0 | |
Dec 31 2020 | WIZP | Wize Pharma, Inc. | Danenberg Noam | Chief Executive Off ... | Option Exercise | X | 0.16 | 125,000 | 20,000 | 0 | |
Dec 31 2020 | WIZP | Wize Pharma, Inc. | Danenberg Noam | Chief Executive Off ... | Sell | S | 0.00 | 507 | 0 | 2,804,227 | 2.8 M to 2.8 M (-0.02 %) |
Dec 31 2020 | WIZP | Wize Pharma, Inc. | Danenberg Noam | Chief Executive Off ... | Buy | X | 0.00 | 63,236 | 0 | 2,804,734 | 2.7 M to 2.8 M (+2.31 %) |
Dec 31 2020 | WIZP | Wize Pharma, Inc. | Danenberg Noam | Chief Executive Off ... | Sell | S | 0.00 | 1,447 | 0 | 2,741,498 | 2.7 M to 2.7 M (-0.05 %) |
Dec 31 2020 | WIZP | Wize Pharma, Inc. | Danenberg Noam | Chief Executive Off ... | Buy | X | 0.00 | 173,607 | 0 | 2,742,945 | 2.6 M to 2.7 M (+6.76 %) |
Dec 31 2020 | WIZP | Wize Pharma, Inc. | Danenberg Noam | Chief Executive Off ... | Sell | S | 0.00 | 12,543 | 0 | 2,569,338 | 2.6 M to 2.6 M (-0.49 %) |
Dec 31 2020 | WIZP | Wize Pharma, Inc. | Danenberg Noam | Chief Executive Off ... | Buy | X | 0.00 | 1,505,162 | 0 | 2,581,881 | 1.1 M to 2.6 M (+139.79 %) |
Dec 31 2020 | WIZP | Wize Pharma, Inc. | Danenberg Noam | Chief Executive Off ... | Sell | S | 0.00 | 962 | 0 | 1,076,719 | 1.1 M to 1.1 M (-0.09 %) |
Dec 31 2020 | WIZP | Wize Pharma, Inc. | Danenberg Noam | Chief Executive Off ... | Buy | X | 0.00 | 125,000 | 0 | 1,077,681 | 952.7 K to 1.1 M (+13.12 %) |
Dec 31 2020 | WIZP | Wize Pharma, Inc. | Rubini Jonathan Brian | 10% Owner | Option Exercise | X | 1.97 | 259,037 | 510,303 | 0 | |
Dec 31 2020 | WIZP | Wize Pharma, Inc. | Rubini Jonathan Brian | 10% Owner | Option Exercise | X | 0.16 | 350,000 | 56,000 | 0 | |
Dec 31 2020 | WIZP | Wize Pharma, Inc. | Rubini Jonathan Brian | 10% Owner | Option Exercise | X | 0.27 | 4,074,074 | 1,100,000 | 0 | |
Dec 31 2020 | WIZP | Wize Pharma, Inc. | Rubini Jonathan Brian | 10% Owner | Sell | S | 0.00 | 2,159 | 0 | 7,100,048 | 7.1 M to 7.1 M (-0.03 %) |
Dec 31 2020 | WIZP | Wize Pharma, Inc. | Rubini Jonathan Brian | 10% Owner | Buy | X | 0.00 | 259,037 | 0 | 7,102,207 | 6.8 M to 7.1 M (+3.79 %) |
Dec 31 2020 | WIZP | Wize Pharma, Inc. | Rubini Jonathan Brian | 10% Owner | Sell | S | 0.00 | 2,692 | 0 | 6,843,170 | 6.8 M to 6.8 M (-0.04 %) |
Dec 31 2020 | WIZP | Wize Pharma, Inc. | Rubini Jonathan Brian | 10% Owner | Buy | X | 0.00 | 350,000 | 0 | 6,845,862 | 6.5 M to 6.8 M (+5.39 %) |
Dec 31 2020 | WIZP | Wize Pharma, Inc. | Rubini Jonathan Brian | 10% Owner | Sell | S | 0.00 | 33,951 | 0 | 6,495,862 | 6.5 M to 6.5 M (-0.52 %) |
Dec 31 2020 | WIZP | Wize Pharma, Inc. | Rubini Jonathan Brian | 10% Owner | Buy | X | 0.00 | 4,074,074 | 0 | 6,529,813 | 2.5 M to 6.5 M (+165.90 %) |
Aug 13 2020 | WIZP | Wize Pharma, Inc. | SIECZKAREK MARK M | Director | Option Exercise | A | 0.00 | 150,000 | 0 | 150,000 | |
Aug 13 2020 | WIZP | Wize Pharma, Inc. | Zarzewsky Joseph | Director | Option Exercise | A | 0.00 | 100,000 | 0 | 100,000 | |
Aug 13 2020 | WIZP | Wize Pharma, Inc. | Belkin Michael | Director | Option Exercise | A | 0.00 | 100,000 | 0 | 100,000 | |
Feb 06 2020 | WIZP | Wize Pharma, Inc. | Rimon Gold Assets Ltd | 10% Owner | Option Exercise | J | 0.27 | 350,334 | 94,590 | 350,334 | |
Feb 06 2020 | WIZP | Wize Pharma, Inc. | Rimon Gold Assets Ltd | 10% Owner | Option Exercise | P | 0.27 | 3,385,212 | 914,007 | 3,385,212 | |
Feb 06 2020 | WIZP | Wize Pharma, Inc. | Rimon Gold Assets Ltd | 10% Owner | Option Exercise | J | 1.10 | 520,820 | 572,902 | 520,820 | |
Feb 06 2020 | WIZP | Wize Pharma, Inc. | Rimon Gold Assets Ltd | 10% Owner | Option Exercise | P | 1.00 | 400,000 | 400,000 | 400,000 | |
Feb 06 2020 | WIZP | Wize Pharma, Inc. | Rimon Gold Assets Ltd | 10% Owner | Option Exercise | P | 1.10 | 400,000 | 440,000 | 400,000 | |
Feb 06 2020 | WIZP | Wize Pharma, Inc. | Rimon Gold Assets Ltd | 10% Owner | Buy | C | 0.27 | 1,692,606 | 457,004 | 6,966,414 | 5.3 M to 7 M (+32.09 %) |
Feb 06 2020 | WIZP | Wize Pharma, Inc. | Rimon Gold Assets Ltd | 10% Owner | Buy | P | 1.00 | 400,000 | 400,000 | 2,985,483 | 2.6 M to 3 M (+15.47 %) |
Dec 26 2019 | WIZP | Wize Pharma, Inc. | Rubini Jonathan Brian | 10% Owner | Option Exercise | P | 0.27 | 4,074,047 | 1,099,993 | 4,074,047 | |
Dec 26 2019 | WIZP | Wize Pharma, Inc. | Rubini Jonathan Brian | 10% Owner | Buy | P | 0.27 | 2,037,037 | 550,000 | 2,455,739 | 418.7 K to 2.5 M (+486.51 %) |
Dec 17 2019 | WIZP | Wize Pharma, Inc. | Danenberg Noam | Chief Executive Off ... | Option Exercise | J | 0.27 | 31,146 | 8,409 | 94,382 | |
Dec 17 2019 | WIZP | Wize Pharma, Inc. | Danenberg Noam | Chief Executive Off ... | Option Exercise | J | 0.27 | 1,505,162 | 406,394 | 1,505,162 | |
Dec 17 2019 | WIZP | Wize Pharma, Inc. | Danenberg Noam | Chief Executive Off ... | Buy | C | 0.00 | 752,581 | 0 | 952,681 | 200.1 K to 952.7 K (+376.10 %) |
Sep 16 2019 | WIZP | Wize Pharma, Inc. | Eisenberg Or | COO, CFO, Treas & S ... | Option Exercise | M | 0.00 | 17,500 | 0 | 162,600 | |
Sep 16 2019 | WIZP | Wize Pharma, Inc. | Eisenberg Or | COO, CFO, Treas & S ... | Buy | M | 0.00 | 17,500 | 0 | 17,500 | 0 to 17.5 K |
Sep 16 2019 | WIZP | Wize Pharma, Inc. | Keret Yosef | Director | Option Exercise | M | 0.00 | 12,500 | 0 | 87,500 | |
Sep 16 2019 | WIZP | Wize Pharma, Inc. | Keret Yosef | Director | Buy | M | 0.00 | 12,500 | 0 | 12,500 | 0 to 12.5 K |
Sep 16 2019 | WIZP | Wize Pharma, Inc. | Danenberg Noam | Chief Executive Off ... | Option Exercise | M | 0.00 | 17,500 | 0 | 122,500 | |
Sep 16 2019 | WIZP | Wize Pharma, Inc. | Danenberg Noam | Chief Executive Off ... | Buy | M | 0.00 | 17,500 | 0 | 142,500 | 125 K to 142.5 K (+14.00 %) |
Sep 16 2019 | WIZP | Wize Pharma, Inc. | Belkin Michael | Director | Option Exercise | A | 0.00 | 12,500 | 0 | 87,500 | |
Sep 16 2019 | WIZP | Wize Pharma, Inc. | Belkin Michael | Director | Buy | M | 0.00 | 12,500 | 0 | 12,500 | 0 to 12.5 K |
Sep 16 2019 | WIZP | Wize Pharma, Inc. | Franck Amouyal | Director | Option Exercise | M | 0.00 | 12,500 | 0 | 87,500 | |
Sep 16 2019 | WIZP | Wize Pharma, Inc. | Franck Amouyal | Director | Buy | M | 0.00 | 12,500 | 0 | 12,500 | 0 to 12.5 K |
Sep 16 2019 | WIZP | Wize Pharma, Inc. | Zarzewsky Joseph | Director | Option Exercise | M | 0.00 | 12,500 | 0 | 87,500 | |
Sep 16 2019 | WIZP | Wize Pharma, Inc. | Zarzewsky Joseph | Director | Buy | M | 0.00 | 12,500 | 0 | 12,500 | 0 to 12.5 K |
Jun 10 2019 | WIZP | Wize Pharma, Inc. | Danenberg Noam | Chief Executive Off ... | Option Exercise | P | 1.10 | 173,607 | 190,968 | 173,607 | |
Apr 23 2019 | WIZP | Wize Pharma, Inc. | Danenberg Noam | Chief Executive Off ... | Option Exercise | P | 1.00 | 125,000 | 125,000 | 125,000 | |
Apr 23 2019 | WIZP | Wize Pharma, Inc. | Danenberg Noam | Chief Executive Off ... | Option Exercise | P | 1.10 | 125,000 | 137,500 | 125,000 | |
Apr 23 2019 | WIZP | Wize Pharma, Inc. | Danenberg Noam | Chief Executive Off ... | Option Exercise | P | 1.33 | 94,382 | 125,717 | 94,382 | |
Apr 23 2019 | WIZP | Wize Pharma, Inc. | Danenberg Noam | Chief Executive Off ... | Option Exercise | P | 1.11 | 265,531 | 295,058 | 265,531 | |
Apr 23 2019 | WIZP | Wize Pharma, Inc. | Danenberg Noam | Chief Executive Off ... | Buy | P | 1.00 | 125,000 | 125,000 | 165,100 | 40.1 K to 165.1 K (+311.72 %) |
Apr 23 2019 | WIZP | Wize Pharma, Inc. | Ridge Valley Corp | 10% Owner | Option Exercise | S | 1.33 | 94,382 | 125,717 | 0 | |
Apr 23 2019 | WIZP | Wize Pharma, Inc. | Ridge Valley Corp | 10% Owner | Option Exercise | S | 1.11 | 265,531 | 295,058 | 0 | |
Apr 23 2019 | WIZP | Wize Pharma, Inc. | Ridge Valley Corp | 10% Owner | Option Exercise | S | 1.33 | 94,382 | 125,717 | 0 | |
Apr 23 2019 | WIZP | Wize Pharma, Inc. | Ridge Valley Corp | 10% Owner | Option Exercise | S | 1.11 | 265,531 | 295,058 | 0 | |
Apr 02 2019 | WIZP | Wize Pharma, Inc. | Zarzewsky Joseph | Director | Option Exercise | A | 0.00 | 100,000 | 0 | 100,000 | |
Apr 02 2019 | WIZP | Wize Pharma, Inc. | Keret Yosef | Director | Option Exercise | A | 0.00 | 100,000 | 0 | 100,000 | |
Apr 02 2019 | WIZP | Wize Pharma, Inc. | Eisenberg Or | Acting CEO, CFO, Tr ... | Option Exercise | A | 0.00 | 140,000 | 0 | 180,100 | |
Apr 02 2019 | WIZP | Wize Pharma, Inc. | Danenberg Noam | Chairman | Option Exercise | A | 0.00 | 140,000 | 0 | 180,100 | |
Apr 02 2019 | WIZP | Wize Pharma, Inc. | Belkin Michael | Director | Option Exercise | A | 0.00 | 100,000 | 0 | 100,000 | |
Apr 02 2019 | WIZP | Wize Pharma, Inc. | Franck Amouyal | Director | Option Exercise | A | 0.00 | 100,000 | 0 | 100,000 | |
Jun 04 2018 | WIZP | Wize Pharma, Inc. | Belkin Michael | Director | Option Exercise | A | 3.59 | 25,000 | 89,750 | 0 | |
May 09 2018 | WIZP | Wize Pharma, Inc. | Rimon Gold Assets Ltd | 10% Owner | Option Exercise | C | 1.31 | 217,442 | 284,414 | 392,055 | |
May 09 2018 | WIZP | Wize Pharma, Inc. | Rimon Gold Assets Ltd | 10% Owner | Buy | C | 1.31 | 217,442 | 284,414 | 1,770,802 | 1.6 M to 1.8 M (+14.00 %) |
May 08 2018 | WIZP | Wize Pharma, Inc. | Sadan Simcha | 10% Owner | Option Exercise | X | 1.97 | 144,168 | 284,415 | 114,869 | |
May 08 2018 | WIZP | Wize Pharma, Inc. | Sadan Simcha | 10% Owner | Buy | X | 1.97 | 144,168 | 284,415 | 682,843 | 538.7 K to 682.8 K (+26.76 %) |
May 08 2018 | WIZP | Wize Pharma, Inc. | Ridge Valley Corp | 10% Owner | Option Exercise | C | 1.33 | 213,524 | 284,414 | 94,853 | |
May 08 2018 | WIZP | Wize Pharma, Inc. | Ridge Valley Corp | 10% Owner | Buy | C | 1.33 | 213,524 | 284,414 | 1,394,805 | 1.2 M to 1.4 M (+18.08 %) |
May 01 2018 | WIZP | Wize Pharma, Inc. | Keret Yosef | Director | Option Exercise | A | 3.59 | 25,000 | 89,750 | 0 | |
May 01 2018 | WIZP | Wize Pharma, Inc. | Zarzewsky Joseph | Director | Option Exercise | A | 3.59 | 25,000 | 89,750 | 0 | |
May 01 2018 | WIZP | Wize Pharma, Inc. | Mayron Ron | Director | Option Exercise | A | 3.59 | 46,500 | 166,935 | 0 | |
May 01 2018 | WIZP | Wize Pharma, Inc. | Mayron Ron | Director | Grant | A | 0.00 | 40,000 | 0 | 66,259 | 26.3 K to 66.3 K (+152.33 %) |
May 01 2018 | WIZP | Wize Pharma, Inc. | Eisenberg Or | Acting CEO, CFO, Tr ... | Option Exercise | A | 3.59 | 36,000 | 129,240 | 0 | |
May 01 2018 | WIZP | Wize Pharma, Inc. | Eisenberg Or | Acting CEO, CFO, Tr ... | Grant | A | 0.00 | 40,100 | 0 | 40,100 | 0 to 40.1 K |
May 01 2018 | WIZP | Wize Pharma, Inc. | Danenberg Noam | Chief Operating Off ... | Option Exercise | A | 3.59 | 36,000 | 129,240 | 0 | |
May 01 2018 | WIZP | Wize Pharma, Inc. | Danenberg Noam | Chief Operating Off ... | Grant | A | 0.00 | 40,100 | 0 | 98,515 | 58.4 K to 98.5 K (+68.65 %) |
May 01 2018 | WIZP | Wize Pharma, Inc. | Franck Amouyal | Director | Option Exercise | A | 3.59 | 25,000 | 89,750 | 0 | |
Jan 22 2018 | DCMG | Wize Pharma, Inc. | Zarachia Yaakov | 10% Owner | Buy | P | 0.12 | 5,000 | 600 | 12,371,892 | 12.4 M to 12.4 M (+0.04 %) |
Jan 19 2018 | DCMG | Wize Pharma, Inc. | Zarachia Yaakov | 10% Owner | Buy | P | 0.15 | 10,000 | 1,450 | 12,366,892 | 12.4 M to 12.4 M (+0.08 %) |
Jan 19 2018 | DCMG | Wize Pharma, Inc. | Zarachia Yaakov | 10% Owner | Buy | P | 0.15 | 13,000 | 1,944 | 12,356,892 | 12.3 M to 12.4 M (+0.11 %) |
Jan 16 2018 | DCMG | Wize Pharma, Inc. | Zarachia Yaakov | 10% Owner | Buy | P | 0.14 | 9,281 | 1,318 | 12,343,892 | 12.3 M to 12.3 M (+0.08 %) |
Jan 16 2018 | DCMG | Wize Pharma, Inc. | Zarachia Yaakov | 10% Owner | Buy | P | 0.15 | 4,000 | 600 | 12,334,674 | 12.3 M to 12.3 M (+0.03 %) |
Jan 16 2018 | DCMG | Wize Pharma, Inc. | Zarachia Yaakov | 10% Owner | Buy | P | 0.11 | 9,841 | 1,033 | 12,330,674 | 12.3 M to 12.3 M (+0.08 %) |
Jan 08 2018 | DCMG | Wize Pharma, Inc. | Zarachia Yaakov | 10% Owner | Buy | P | 0.09 | 7,507 | 638 | 12,320,833 | 12.3 M to 12.3 M (+0.06 %) |
Jan 02 2018 | DCMG | Wize Pharma, Inc. | Zarachia Yaakov | 10% Owner | Buy | P | 0.11 | 20,711 | 2,278 | 12,313,326 | 12.3 M to 12.3 M (+0.17 %) |
Jan 02 2018 | DCMG | Wize Pharma, Inc. | Zarachia Yaakov | 10% Owner | Buy | P | 0.11 | 9,289 | 1,022 | 12,292,615 | 12.3 M to 12.3 M (+0.08 %) |
May 13 2013 | DCMG | OphthaliX, Inc. | Weinstein Itay | Chief Financial Off ... | Option Exercise | A | 1.29 | 117,500 | 151,575 | 117,500 | |
May 08 2013 | DCMG | OphthaliX, Inc. | Singer Barak | Chief Executive Off ... | Option Exercise | A | 1.18 | 469,854 | 552,407 | 939,708 | |
May 08 2013 | DCMG | OphthaliX, Inc. | Singer Barak | Chief Executive Off ... | Option Exercise | A | 1.18 | 469,854 | 552,407 | 469,854 | |
Mar 20 2012 | DCMG | OphthaliX, Inc. | Regev Guy | Director | Buy | P | 63,677.00 | 32,072 | 2,042,248,744 | 255,535 | 223.5 K to 255.5 K (+14.35 %) |
Nov 23 2011 | DCMG | OphthaliX, Inc. | Rule Matthew | Sell | S | 7,750.00 | 7,750,000 | 60,062,500,000 | 250,000 | 8 M to 250 K (-96.87 %) |
Page: 1